GELSNasdaqPharmaceutical PreparationsFiscal year ends June 30
Gelteq Ltd
Financials through fiscal 2025, year ended Jun 30, 2025Last filing: 20-F on Nov 17, 2025
$0.43−0.02 (-3.50%)
Close on Oct 19, 2026
Share price
−$0.7896 (−64.72%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Gelteq Ltd reported revenue of A$165.65K for fiscal 2025. Free cash flow was -A$5.52M.
Revenue
A$165.65K
FY2025
Operating income
-A$5.50M
FY2025
Free cash flow
-A$5.52M
FY2025
EPS, diluted
-0.72 AUD
FY2025
Key statistics
Valuation at the latest close; fundamentals over fiscal 2025, balances at Dec 31, 2025
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- A$165.65K
- EPS, diluted
- -0.72 AUD
- Free cash flow
- -A$5.52M
Valuation needs the share price. It fills in once daily prices are connected and converted from AUD.
Four years at a glance
Fiscal years 2022 to 2025, AUD
Revenue
A$165.65K
Gross profit
A$50.25K
Operating income
-A$5.50M
Net income
–
EPS, diluted
-0.72 AUD
Free cash flow
-A$5.52M
Reported period